Gonadotropin Releasing Hormone Antagonist Plus Testosterone

Experimental Procedures
Adult male monkeys, Macaca fascicularis, were housed under controlled conditions of temperature (21 ± 2°C) and light (on at 0600 h, off at 1800 h) in individual cages at the Regional Primate Center at the University of Washington. In addition to monkey chow, the animals received fresh fruit, chewable vitamins, and iron injections. The animals were aged 8 to 15 years (as assessed by dental radiographs). The GnRH antagonist (supplied courtesy of Drs. Brian Vickery and John 1. Nestor of the Syntex Corporation, Palo Alto, CA) was dissolved at a concentration of 4llg/ml in a vehicle containing glacial acetic acid, benzyl alcohol, sodium hydroxide, and sterile water. The vehicle was supplied by the Syntex Corporation and contained 0.02M sodium acetate buffer, 0.9% benzyl alcohol preservative, and 0.02 M glacial acetic acid. Antagonist was added to this solution and was filtered through a 0.81lm nucleopore filter. Aliquots of 20 ml were frozen at -20°C until use. During the study period, either the antagonist or the vehicle was injected subcutaneously daily between 0800 hand 1200 h.
All animals in the experimental groups received Silastic capsule implants subcutaneously 5 days prior to the first injection of GnRH antagonist. The capsules were 0.33cm ID X 0.46cm OD and were 5.5cm in length. These implants contained either crystalline testosterone or were empty, depending on the treatment regimen. Capsules were sterilized in Zephiran and rinsed in sterile saline before implantation. Implants were removed when injections of GnRH antagonist were completed.
Serum testosterone was measured by radioimmunoassay, using methods previously described (1). The minimum detectability of the assay was less than 0.35 nmollL. The intra-and interassay coefficients of variation were 5.1 % and 9.8%, respectively. GnRH antagonist levels were measured in groups 2, 3, and 4 by RIA at the Syntex Corporation. Seminal fluid was obtained by rectal electroejaculation. Sperm counts were performed in the Seminal Fluid Core Laboratory (c. Alvin Paulsen, Director) of the Population Center for Research in Reproduction.
All animals (n = 22) were studied for an initial 4-month control period during which baseline measurements were obtained. The animals were then divided into four groups: Group 1 (n = 5) received antagonist, 250 Ilg/kg/day, plus sham implants, for 12 weeks. Group 2 (n = 5) received GnRH antagonist, 250 Ilg/kg/day plus T via implants for 20 weeks. Group 3 (n = 5) received antagonist, 750 Ilg/kg/day, plus T via implants for 16 weeks. Group 4 (n = 7) received vehicle alone for 20 weeks. Animals were monitored daily and observed for any physical or behavioral effects of the drug treatment. Throughout the control and experimental periods, seminal fluid, blood samples, and body weights were obtained every 2 weeks.
